Below is a collection of video sessions with experts from PhRMA commenting on various aspects of ongoing PhRMA member company efforts to support the detection, prevention and treatment of the coronavirus outbreak.

Stephen J. Ubl

PhRMA president and CEO Stephen J. Ubl shares how biopharmaceutical companies are working to develop safe and effective COVID-19 vaccines that will allow us to get back to our everyday lives. 

The biopharmaceutical industry is coming together to beat coronavirus. Through enhancing testing availability and working closely with hospitals and physicians on hundreds of clinical trials for existing and new treatments and vaccines, biopharmaceutical companies are working around the clock to find effective solutions to beat the virus.

Click or tap the video to learn more.

Lori Reilly

PhRMA chief operating officer Lori Reilly gives insight into how companies are working to ensure patients get access to the treatments they need.

The biopharmaceutical industry is coming together to beat coronavirus. Through enhancing testing availability and working closely with hospitals and physicians on hundreds of clinical trials for existing and new treatments and vaccines, biopharmaceutical companies are working around the clock to find effective solutions for you.

Click or tap the video to learn more.

Michael Ybarra

Dr. Michael Ybarra, emergency medicine physician and vice president of medical affairs and strategic alliances at PhRMA, shares how biopharmaceutical companies have donated resources, equipment, time and expertise to beat COVID-19.

The biopharmaceutical industry is coming together to take on one singular challenge: beat coronavirus. Through enhancing testing availability and working closely with hospitals and physicians on hundreds of clinical trials for existing and new treatments and vaccines, biopharmaceutical companies are working around the clock to find effective solutions for you.

Click or tap the video to learn more.

Richard Moscicki

Dr. Richard Moscicki, PhRMA’s chief medical officer and Executive Vice President of Science and Regulatory Advocacy, showcases the science behind creating a vaccine and how the biopharmaceutical industry’s rapid response to COVID-19 proves that science is how we get back to normal.

The biopharmaceutical industry is coming together to take on one singular challenge: beat coronavirus. Through enhancing testing availability and working closely with hospitals and physicians on hundreds of clinical trials for existing and new treatments and vaccines, biopharmaceutical companies are working around the clock to find effective solutions for you.

Click or tap the video to learn more.